Press Resease

Surgical Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others) and by Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 02-Jul-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4287 Status : Published

Global surgical tumor ablation market expected to generate around USD 2,256 million by 2025, at a CAGR of around 11.6% between 2019 and 2025. Increasing prevalence of cancer across the globe is creating the demand for an efficient and effective treatment that can improve patient health at a relatively lower time, with minimal invasion and pain and at affordable costs.

Description

The report covers a forecast and an analysis of the surgical tumor ablation market on a global and regional level. The study provides historical data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the surgical tumor ablation market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the surgical tumor ablation market on a global level.

In order to give the users of this report a comprehensive view of the surgical tumor ablation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Surgical Tumor Ablation Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the surgical tumor ablation market by segmenting it based on technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global surgical tumor ablation market are Galil Medical, Misonix, HealthTronics, AngioDynamics, Covidien, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, and NeuWave Medical.

This report segments the global surgical tumor ablation market into:

Global Surgical Tumor Ablation Market: Technology Analysis

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Others

Global Surgical Tumor Ablation Market: Application Analysis

  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

Global Surgical Tumor Ablation Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Surgical Tumor Ablation Market, 2017-2025 (USD Million)
    • 2.2. Global Surgical Tumor Ablation Market: Snapshot
  •  
  • Chapter 3. Tumor Ablation Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Surgical Tumor Ablation Market drivers: Impact analysis
      • 3.2.2. Growing Geriatric Population Globally
      • 3.2.3. Increasing Population Base of Cancer Patients
      • 3.2.4. Technological Advancements in Ablation Devices
    • 3.3. Market Restraints
      • 3.3.1. Global Surgical Tumor Ablation Market restraints: Impact analysis
      • 3.3.2. Cost Containment Measures By Various Governments
      • 3.3.3. Ongoing Healthcare Reforms in the U.S.
    • 3.4. Opportunities
      • 3.4.1. Growth Potential Offered By Emerging Markets
      • 3.4.2. Growing Awareness About Ablation Procedures
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Technology
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Surgical Tumor Ablation Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Surgical Tumor Ablation Market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Surgical Tumor Ablation Market- Technology Analysis
    • 5.1. Global Surgical Tumor Ablation Market: Technology overview
      • 5.1.1. Global Surgical Tumor Ablation Market revenue share, by Technology, 2018 and 2025
    • 5.2. Radiofrequency Ablation
      • 5.2.1. Global Radiofrequency Ablation, 2017-2025 (USD Million)
    • 5.3. Microwave Ablation
      • 5.3.1. Global Microwave Ablation market, 2017-2025 (USD Million)
    • 5.4. Cryoablation
      • 5.4.1. Global Cryoablation market, 2017-2025 (USD Million)
    • 5.5. Others
      • 5.5.1. Global Others market, 2017-2025 (USD Million)
  •  
  • Chapter 6. Global Surgical Tumor Ablation Market - Application Analysis
    • 6.1. Global Surgical Tumor Ablation Market: Application overview
      • 6.1.1. Global Surgical Tumor Ablation Market Revenue share, by application, 2017- 2025
    • 6.2. Liver Cancer
      • 6.2.1. Global Surgical Tumor Ablation Market for Liver Cancer, 2017-2025 (USD Million)
    • 6.3. Breast Cancer
      • 6.3.1. Global Surgical Tumor Ablation Market for Breast Cancer,2017-2025 (USD Million)
    • 6.4. Lung Cancer
      • 6.4.1. Global Surgical Tumor Ablation Market for Lung Cancer, 2017-2025 (USD Million)
    • 6.5. Prostate Cancer
      • 6.5.1. Global Surgical Tumor Ablation Market for Prostate Cancer, 2017-2025 (USD Million)
    • 6.6. Others
      • 6.6.1. Global Surgical Tumor Ablation Market for Others, 2017-2025 (USD Million)
  •  
  • Chapter 7. Global Surgical Tumor Ablation Market - Regional Analysis
    • 7.1. Global Surgical Tumor Ablation Market: Regional overview
      • 7.1.1. Global Surgical Tumor Ablation Market Revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
      • 7.2.2. North America Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.2.3.2. The U.S. Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.2.4. Canada
        • 7.2.4.1. Canada Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.2.4.2. Canada Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
      • 7.3.2. Europe Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.3.3.2. Germany Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.3.4. France
        • 7.3.4.1. France Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.3.4.2. France Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.3.5. UK
        • 7.3.5.1. UK Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.3.5.2. UK Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.3.6.2. Rest of Europe Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
      • 7.4.2. Asia Pacific Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.4.3. China
        • 7.4.3.1. China Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.4.3.2. China Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.4.4.2. Japan Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.4.5. India
        • 7.4.5.1. India Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.4.5.2. India Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.4.6.2. Rest of Asia Pacific Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
      • 7.5.2. Latin America Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.5.3.2. Brazil Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
        • 7.5.4.2. Rest of Latin America Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Surgical Tumor Ablation Market Revenue, by Technology, 2017-2025 (USD Million)
      • 7.6.2. The Middle East and Africa Surgical Tumor Ablation Market Revenue, by application, 2017-2025 (USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Galil Medical
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Misonix
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. HealthTronics
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. AngioDynamics
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Covidien
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Boston Scientific Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Medtronic
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. SonaCare Medical
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. EDAP TMS
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Neuwave Medical
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments

Methodology

Free Analysis

Tumor ablation is referred to as a minimally-invasive technique for the treatment or destruction of cancer cells. Certain probes like needles are used to freeze or burn cancerous cells without conventional surgical treatment. The imaging techniques like MRI), ultrasound, or CT scans are used to direct, position, and guide the needle probe to the tumor. When the probe is within the cancerous cell through a tiny hole, it gets bind to a generator that burns or freezes cancer.

Increasing prevalence of cancer across the globe is creating the demand for an efficient and effective treatment that can improve patient health at a relatively lower time, with minimal invasion and pain and at affordable costs. This is the primary growth driver of the global surgical tumor ablation market. Other prominent factors boosting the surgical tumor ablation market growth are the rising awareness about the advantages of tumor ablation over conventional treatment methods and growing investments made in tumor ablation techniques worldwide. Furthermore, technological advancements related to the thermal ablation technique are also expected to fuel the surgical tumor ablation market growth in the upcoming years. However, the change in government reforms may hinder the global surgical tumor ablation market growth in the years ahead.

Global Surgical Tumor Ablation Market

The global surgical tumor ablation market is fragmented on the basis of technology and application. Based on technology, the market includes cryoablation, microwave ablation, radiofrequency ablation, and others. By technology, the microwave ablation segment is expected to register the highest growth rate in the future, due to product related technological advancements and benefits like consistency in high temperature, lower procedural pain, larger tumor ablation volume, and optimal heating of the cystic mass. By application, the global surgical tumor ablation market is categorized into lung cancer, prostate cancer, breast cancer, liver cancer, and others. The liver cancer segment is estimated to hold a notable market share in 2018, whereas the lung cancer segment is expected to show a high CAGR over the forecast time period.

The North American surgical tumor ablation market is anticipated to continue its regional dominance over the forecast timeframe as well. This can be attributed to Well-planned and implemented healthcare reforms, high adoption of advance therapeutic procedure, increasing prevalence of cancer, and high purchasing power of the regional population. Europe held the second spot in the global surgical tumor ablation market followed by the Asia Pacific. The Asia Pacific surgical tumor ablation market is proposed to register the highest growth rate over the projected timeframe, owing to the increasing cancer prevalence, rising disposable income of the regional population, and growing number of government initiative with favorable reimbursement policies.

Some key players of the global surgical tumor ablation market are Galil Medical, Misonix, HealthTronics, AngioDynamics, Covidien, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, and NeuWave Medical.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com